A Novel Mutation in the Lysyl Hydroxylase 1 Gene Causes Decreased Lysyl Hydroxylase Activity in an Ehlers–Danlos VIA Patient
- 1 May 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (5) , 914-918
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 geneMolecular Genetics and Metabolism, 2004
- Heterogeneous basis of the type VIB form of Ehlers–Danlos syndrome (EDS VIB) that is unrelated to decreased collagen lysyl hydroxylationAmerican Journal of Medical Genetics Part A, 2004
- Identification, expression, and tissue distribution of the three rat lysyl hydroxylase isoformsBiochemical and Biophysical Research Communications, 2003
- Mutations in the Lysyl Hydroxylase 1 Gene That Result in Enzyme Deficiency and the Clinical Phenotype of Ehlers–Danlos Syndrome Type VIMolecular Genetics and Metabolism, 2000
- Mutational analysis of the lysyl hydroxylase 1 gene (PLOD) in six unrelated patients with Ehlers-Danlos syndrome type VI: Prenatal exclusion of this disorder in one familyHuman Mutation, 2000
- Deletion of cysteine 369 in lysyl hydroxylase 1 eliminates enzyme activity and causes Ehlers–Danlos syndrome type VIMatrix Biology, 2000
- Substitution of glycine-661 by serine in the α1(I) and α2(1) chains of type I collagen results in different clinical and biochemical phenotypesHuman Genetics, 1996
- The Expression of a Functional, Secreted Human Lysyl Hydroxylase in a Baculovirus SystemJournal of Investigative Dermatology, 1996
- Serum Stimulation of Lysyl Hydroxylase Activity in Cultured Human Skin FibroblastsConnective Tissue Research, 1985
- A Heritable Disorder of Connective TissueNew England Journal of Medicine, 1972